CoChat
Sign Up
Cited by 180Reproductive tract infections researchAntifungal resistance and susceptibilityUrinary Tract Infections Management

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Recurrent vulvovaginal candidiasis

Blostein, Freida, Levin-Sparenberg, Elizabeth, Wagner, Julian, Foxman, Betsy·2017·Annals of Epidemiology
DOI 10.1016/j.annepidem.2017.08.010
Open this paper in CoChat — free account

Abstract

Purpose Recurrent vulvovaginal candidiasis (RVVC), multiple episodes of vulvovaginal candidiasis (VVC; vaginal yeast infection) within a 12-month period, adversely affects quality of life, mental health, and sexual activity. Diagnosis is not straightforward, as VVC is defined by the combination of often nonspecific vaginal symptoms and the presence of yeast-which is a common vaginal commensal. Estimating the incidence and prevalence is challenging: most VVC is diagnosed and treated empirically, the availability for purchase of effective therapies over the counter enables self-diagnosis and treatment, and the duration of the relatively benign VVC symptoms is short, introducing errors into any estimates relying on medical records or patient recall.Methods We evaluate current estimates of VVC and RVVC and provide new prevalence estimates using data from a 2011 seven-country (n = 7345) internet panel survey on VVC conducted by Ipsos Health (https://www.ipsos.com/en). We also evaluate information on VVC-associated visits using the National Ambulatory Medical Care Survey.Results The estimated probability of VVC by age 50 varied widely by country (from 23% to 49%, mean 39%), as did the estimated probability of RVVC after VVC (from 14% to 28%, mean 23%).Conclusions However estimated, the probability of RVVC was high suggesting RVVC is a common condition.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.annepidem.2017.08.010

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 77 references

Research works printed but not linked: 5

  1. Gonzales, 1994, Over-the-Counter histamine 2 bocker therapy, Ann Pharm, 28, 392
  2. Foxman, 1998, Frequency and response to vaginal symptoms among White and African American women: results of a random digit dialing survey, J Womens Health, 7, 1167, 10.1089/jwh.1998.7.1167 · DOI
  3. Foxman, 2013, Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey, J Low Genit Tract Dis, 17, 340, 10.1097/LGT.0b013e318273e8cf · DOI · Paper page
  4. Johnson, 2010, Attitudes and experience of women to common vaginal infections, J Low Genit Tract Dis, 14, 287, 10.1097/LGT.0b013e3181d85bb7 · DOI
  5. Khosravi, 2011, A comparison study between the direct agglutination test and conventional methods in the diagnosis of vulvovaginal candidiasis, Comp Clin Path, 20, 639, 10.1007/s00580-010-1050-1 · DOI

Cited by

Sorted by citations

Items 101–179 of 179

Related

See all

Metadata

Authors
Blostein, F., Levin-Sparenberg, E., Wagner, J., & Foxman, B.
Affiliations
University of Michigan (US)
Corresponding author
Foxman, Betsy
ORCID
Venue
Annals of Epidemiology
Publisher
Elsevier BV
Published
2017-09
Volume
27
Issue
9
Pages
575-582.e3
ISSN
1047-2797 (ISSN-L)
DOI
10.1016/j.annepidem.2017.08.010
OpenAlex
W2746230075
Cited by
180
References
77
Citations by year
2026: 13 · 2025: 18 · 2024: 25 · 2023: 27 · 2022: 30 · 2021: 23 · 2020: 23 · 2019: 12 · 2018: 8
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Annals of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
NovaDigm Therapeutics
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Keywords
recurrent vulvovaginal candidiasis, vaginal candidiasis, prevalence, incidence, National Ambulatory Medical Care Survey, yeast infections, quality of life, sexual activity
MeSH terms
Antifungal Agents, Candidiasis, Vulvovaginal, Female, Humans, Quality of Life, Recurrence, Sexual Behavior, Vagina, Incidence, Prevalence, Age Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review